🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Liposarcoma

Hypofractionated, 3-week, Preoperative Proton or X-ray Radiotherapy for Patients With Localized Soft Tissue Sarcoma NCT07169344Phase 24 sites📍 Bergen📍 Oslo📍 Tromsø Oslo University Hospital · Tests: preoperative, Quality of life, Functional outcome N-803 in Patients With Progressive Synovial Sarcoma and Myxoid/Round Cell Liposarcoma Previously Treated With Adoptive Cellular Therapy NCT07261657EARLY Phase 11 site📍 Chicago Seth Pollack · Tests: Biospecimen Collection, Computed Tomography, Leukapheresis, Magnetic Resonance Imaging, Nogapendekin Alfa Inbakicept Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors NCT04557449Phase 1, Phase 239 sites📍 Los Angeles📍 New Haven📍 New Haven Pfizer · Tests: PF-07220060, Letrozole, Fulvestrant, Midazolam, Enzalutamide MASCT-I Combined With Doxorubicin and Ifosfamide for First-line Treatment of Advanced Soft Tissue Sarcoma NCT06277154Phase 21 site📍 Guangzhou HRYZ Biotech Co. · Tests: MASCT-I, Doxorubicin, Ifosfamide International Prospective Registry on Local Treatment Approaches in MLS NCT04699292n/a1 site📍 Amsterdam The Netherlands Cancer Institute · Tests: Surgery, Preoperative RT 36Gy, Preoperative RT 50Gy, Postoperative RT 50-66Gy, RT 36Gy A Study of LN-144 or LN-145 in People With Advanced Uveal Melanoma, Undifferentiated Pleomorphic Sarcoma, Dedifferentiated Liposarcoma, or Angiosarcoma NCT05607095Phase 12 sites📍 Harrison📍 New York Memorial Sloan Kettering Cancer Center · Tests: Lifileucel (LN-144/LN-145) First-in-Human Trial of DS-2243a in Participants With Advanced Solid Tumors NCT06644755Phase 17 sites📍 Boston📍 New York📍 Nashville Daiichi Sankyo · Tests: DS-2243a Immunotherapy for Solid Tumor Malignancies in Pediatrics Using Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor T Cells NCT07148050Phase 11 site📍 Seattle Seattle Children's Hospital · Tests: SC-CAR.GPC3xIL15.21 CAR T cells IO Combined With AI as First-line Treatment for Patients With Soft Tissue Sarcoma(TAIS) NCT06849986Phase 21 site📍 Shanghai Fudan University · Tests: Tislelizumab+liposomal doxorubicin+ifosfamide Identification of a New Blood Biomarker for the Diagnosis and Prognosis of Liposarcomas NCT04224064NA1 site📍 Montpellier Institut du Cancer de Montpellier - Val d'Aurelle · Tests: Blood sampling A Study of Mirdametinib in Combination With Palbociclib in People With Liposarcoma NCT06843967Phase 1, Phase 27 sites📍 Basking Ridge📍 Middletown📍 Montvale Memorial Sloan Kettering Cancer Center · Tests: Mirdametinib, Palbociclib NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS) NCT06239272Phase 1, Phase 27 sites📍 Atlanta📍 Chicago📍 Baton Rouge St. Jude Children's Research Hospital · Tests: Surgical resection, Proton beam radiation therapy, Pazopanib, Ifosfamide, Doxorubicin A Phase 3 Study of Ersodetug in Patients With Tumor Hyperinsulinism NCT06881992Phase 313 sites📍 Chicago📍 Bethesda📍 Boston Rezolute · Tests: Ersodetug A Phase 1 Study of Neoadjuvant Abemaciclib in Combination With Radiation Therapy for Liposarcomas NCT06025747Phase 11 site📍 Seattle University of Washington · Tests: Abemaciclib, Computed Tomography, Magnetic Resonance Imaging, Radiation Therapy, Therapeutic Surgical Procedure Zanzalintinib Combined With Eribulin in Advanced Liposarcoma and Leiomyosarcoma NCT06957431Phase 11 site📍 St Louis Washington University School of Medicine · Tests: Zanzalintinib, Eribulin Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Differentiated Sarcomas NCT06422806Phase 3269 sites📍 Phoenix📍 Tucson📍 Tucson National Cancer Institute (NCI) · Tests: Biospecimen Collection, Diagnostic Imaging Testing, Doxorubicin, Echocardiography Test, Multigated Acquisition Scan Prospective Study Evaluating the Treatment Outcomes for Localised Recurrent, Resectable Retroperitoneal Liposarcoma NCT07377747n/a13 sites📍 Atlanta📍 Boston📍 Columbus Australia and New Zealand Sarcoma Association APG-115 in Combination With PD-1 Inhibitor in Patients With Advanced Liposarcoma or Advanced Solid Tumors NCT04785196Phase 1, Phase 23 sites📍 Guangzhou📍 Hangzhou📍 Shanghai Ascentage Pharma Group Inc. · Tests: APG-115, Toripalimab Dose-escalated, Hypofractionated, Definitive Proton Radiotherapy for Patients With Inoperable Soft Tissue Sarcoma. NCT07173972Phase 22 sites📍 Bergen📍 Oslo Oslo University Hospital · Tests: Definitive radiotherapy A Study to Efficacy and Safety of SPH4336 Monotherapy or in Combination With Cadonilimab in Patients With Advanced Solid Tumors. NCT05944224Phase 1, Phase 216 sites📍 Fuzhou📍 Guangzhou📍 Zhengzhou Shanghai Pharmaceuticals Holding Co., Ltd · Tests: SPH4336, Cadonilimab Trabectedin Plus Radiotherapy in Soft Tissue Sarcoma Patients NCT02275286Phase 1, Phase 217 sites📍 Bordeaux📍 Lyon📍 Rozzano Grupo Espanol de Investigacion en Sarcomas · Tests: Trabectedin, Radiotherapy Phase I/Ib Study of NK Expressing an Affinity-enhanced T-cell Receptor (TCR) Against the NY-ESO-1 NCT06083883Phase 11 site📍 Houston M.D. Anderson Cancer Center · Tests: Fludarabine phosphate, NY-ESO-1 TCR/IL-15 NK, Cyclophosphamide Genomic Risk in Retroperitoneal Sarcoma NCT06436846n/a1 site📍 Philadelphia Fox Chase Cancer Center · Tests: Biospecimen sample collection during standard-of-care surgery A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors NCT06789172Phase 110 sites📍 Beverly Hills📍 Santa Monica📍 Houston Epkin · Tests: OKN4395, Pembrolizumab, Fasting, Fed, H2 Receptor Antagonist A Study of Pembrolizumab in People With Ultra-Rare Sarcomas NCT07089992Phase 27 sites📍 Basking Ridge📍 Middletown📍 Montvale Memorial Sloan Kettering Cancer Center · Tests: Pembrolizumab A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Soft Tissue Sarcoma NCT07741877Phase 22 sites📍 Tampa📍 New York Iovance Biotherapeutics, Inc. · Tests: Lifileucel A Phase 2, Open Label Study of PEmigatinib and REtifanlimab in Advanced Dedifferentiated LIposarcoma (PERELI) NCT06389799Phase 24 sites📍 Oslo📍 Gothenburg📍 Lund Lund University Hospital · Tests: Pemigatinib, Retifanlimab STC-15 as a Part of Combination Therapy With Toripalimab in Selected Advanced Cancers and as Monotherapy in Participants With Selected Sarcomas NCT06975293Phase 1, Phase 214 sites📍 San Francisco📍 Miami📍 Boston STORM Therapeutics LTD · Tests: STC-15 in combination with toripalimab, STC-15 monotherapy Testing the Addition of an Anti-cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (Gemcitabine) for Soft Tissue Sarcoma NCT06498648Phase 1, Phase 21 site📍 Houston National Cancer Institute (NCI) · Tests: Abemaciclib, Biopsy Procedure, Biospecimen Collection, Computed Tomography, Docetaxel Precision Medicine Approaches for Neoadjuvant Therapy in High-risk Sarcoma Patients NCT07432932n/a1 site📍 London Royal Marsden NHS Foundation Trust · Tests: Observational Translational Study
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy